The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).
 
Mateus Trinconi Cunha
No Relationships to Disclose
 
Lucas Stangler
No Relationships to Disclose
 
Pedro Freire
No Relationships to Disclose
 
Paulo Victor Alves Pinto
No Relationships to Disclose
 
Fernando Morbeck Almeida Coelho
No Relationships to Disclose
 
Públio Viana
No Relationships to Disclose
 
Mauricio Cordeiro
No Relationships to Disclose
 
William Carlos Nahas
No Relationships to Disclose
 
Jose Mauricio Mota
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Merck; Pfizer; Zodiac Pharma
Expert Testimony - Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma